Home > Healthcare > Pharmaceutical Analytical Testing Outsourcing Market > Table of Contents

Pharmaceutical Analytical Testing Outsourcing Market – By Services (Bioanalytical Testing [Clinical, Non-clinical], Method Development & Validation, Stability Testing) Product Type (API, Additive, Finished Product), End-user & Forecast, 2024 – 2032

  • Report ID: GMI8572
  • Published Date: Mar 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Base estimates & calculations

1.3    Data collection

1.4    Forecast parameters

1.5    Data validation

1.6    Data sources

1.6.1    Primary

1.6.2    Secondary

1.6.2.1   Paid sources

1.6.2.2   Public sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1   Globalization of the pharmaceutical industry

3.2.1.2   Regulatory framework

3.2.1.3   Growing advancements in analytical instrumentations

3.2.1.4   Increasing outsourcing trends

3.2.2    Industry pitfalls & challenges

3.2.2.1   Quality concerns and risk mitigation

3.2.2.2   Confidentiality and intellectual property protection

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Porter’s analysis

3.5.1    Supplier power

3.5.2    Buyer power

3.5.3    Threat of new entrants

3.5.4    Threat of substitutes

3.5.5    Industry rivalry

3.6    PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company matrix analysis

4.3    Competitive analysis of major market players

4.4    Competitive positioning matrix

4.5    Strategic dashboard

Chapter 5   Market Estimates and Forecast, By Service, 2018 - 2032 ($ Million)

5.1    Key trends

5.2    Bioanalytical testing

5.2.1    Clinical

5.2.2    Non-clinical

5.3    Method development & validation

5.3.1    Extractable & leachable

5.3.2    Impurity method

5.3.3    Technical consulting

5.3.4    Other method development & validation services

5.4    Stability testing

5.4.1    Drug substance testing

5.4.2    Stability indicating method validation

5.4.3    Accelerated stability testing

5.4.4    Photostability testing

5.4.5    Other stability testing services

5.5    Other services

Chapter 6   Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Million)

6.1    Key trends

6.2    Active pharmaceutical ingredient (API)

6.3    Additives

6.4    Finished products

Chapter 7   Market Estimates and Forecast, By End-User, 2018 - 2032 ($ Million)

7.1    Key trends

7.2    Pharmaceutical companies

7.3    Biopharmaceutical companies

7.4    Academics & research institutes

Chapter 8   Market Estimates and Forecast, By Region, 2018 - 2032 ($ Million)

8.1    Key trends, by region

8.2    North America

8.2.1    U.S.

8.2.2    Canada

8.3    Europe

8.3.1    Germany

8.3.2    UK

8.3.3    France

8.3.4    Spain

8.3.5    Italy

8.3.6    Rest of Europe

8.4    Asia Pacific

8.4.1    Japan

8.4.2    China

8.4.3    India

8.4.4    Australia

8.4.5    Rest of Asia Pacific

8.5    Latin America

8.5.1    Brazil

8.5.2    Mexico

8.5.3    Rest of Latin America

8.6    Middle East and Africa

8.6.1    South Africa

8.6.2    Saudi Arabia

8.6.3    Rest of Middle East and Africa

Chapter 9   Company Profiles

9.1    BA Sciences

9.2    Charles River Laboratories International, Inc.

9.3    Eurofins Scientific

9.4    Immunologix Laboratories

9.5    Indoco Analytical Solutions

9.6    Intertek Group plc

9.7    Labcorp Drug Development

9.8    Pace Labs

9.9    SGS Societe Generale de Surveillance SA.

9.10    STERIS

9.11    Thermo fisher Scietific, Inc.

9.12    Triclinic Labs, Inc.

9.13    West Pharmaceutical Services, Inc.

9.14    Wuxi AppTec
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 14
  • Tables & Figures: 412
  • Countries covered: 22
  • Pages: 190
 Download Free Sample